| Issue Date | Title | Author(s) |
| 2019-04-10 | Real-World Cost Effectiveness of Mandatory Folic Acid Fortification of Bread-Making Flour in Australia | Saing, S; Haywood, P; van der Linden, N; Manipis, K; Meshcheriakova, E; Goodall, S |
| 2019-03-01 | Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions | Parkinson, B; Gumbie, M; Cutler, H; Gauld, N; Mumford, V; Haywood, P |
| 2019-01-01 | Cost of Salmonella infections in Australia, 2015 | Ford, L; Haywood, P; Kirk, MD; Lancsar, E; Williamson, DA; Glass, K |
| 2018-08-01 | The prevalence of persistence and related health status: An analysis of persistently high healthcare costs in the short term and medium term | Longden, T; Wong, CY; Haywood, P; Hall, J; van Gool, K |
| 2018-06-01 | Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model | Saing, S; Haywood, P; Duncan, JK; Ma, N; Cameron, AL; Goodall, S |
| 2018-05-01 | Evaluation of the NSW Statewide Eyesight Preschool Screening Program 16247 | Goodall, A; Ryan, R; Furby, B; French, A; Rose, K; Haywood, P; Cronin, P; Goodall, S; Ellinson, A; van den Nieuwenhof, A |
| 2018 | The importance of comorbidity and multimorbidity in determining health care costs: An analysis of the cost amplifications associated with morbidity interaction variables. CHERE Working Paper 2018/01 | Longden, T; Wong, C; Haywood, P; Hall, J; Van Gool, K |
| 2017-10-01 | Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study | Pearce, A; Haas, M; Viney, R; Pearson, SA; Haywood, P; Brown, C; Ward, R |
| 2017-06-01 | Long-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, Australia | Cronin, P; Kirkbride, B; Bang, A; Parkinson, B; Smith, D; Haywood, P |
| 2017-01-01 | Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: Protocol detailing observations in a whole of population cohort | Daniels, B; Lord, SJ; Kiely, BE; Houssami, N; Haywood, P; Lu, CY; Ward, RL; Pearson, SA |
| 2017 | The effectiveness and cost-effectiveness of mandatory folic acid and iodine fortification. A report for the Australian Health Ministers’ Advisory Council | Haywood, P; Goodall, S; Chinchen, E; Haas, M; Manipis, K; Meshcheriakova, O; Saing, S; van der Linden, N |
| 2014 | Rates of chemotherapy adverse event in clinical practice: results from a prospective cohort study | Pearce, AM; Haas, M; Viney, R; Pearson, S; Haywood, P; Ward, R |
| 2012-12-01 | Delays in access to affordable medicines: Putting policy into perspective | Pearce, A; Van Gool, K; Haywood, P; Haas, M |
| 2012-11-22 | Chemotherapy administration: Modelling the costs of alternative protocols | Haywood, P; De Raad, J; Van Gool, K; Haas, M; Gallego, G; Pearson, SA; Faedo, M; Ward, R |
| 2010-12-01 | Nursing takes time: Workload associated with administering Cancer Protocols | de Raad, J; van Gool, K; Haas, M; Haywood, P; Faedo, M; Gallego, G; Pearson, S; Ward, R |
| 2005-01-01 | Alternatives to for-profit corporatisation: The view from general practice | Anderson, R; Haywood, P; Usherwood, T; Haas, M; Hall, J |
| 2003-07-23 | Theory verses empiricism in health economics: An analysis of the past 20 years | Bridges, JFP; Haywood, P |
| 2002-07-23 | Diagnosis and prognosis of Australia's health information for evidence-based policy | Van Gool, K; Lancsar, E; Viney, R; Hall, J; Haywood, P |
